Adherence Analysis: Semaglutide QW Versus Other GLP-1 RAs As a result of the relatively short period of time from the launch of semaglutide QW to the index date, fewer patients receiving semaglutide QW were included in the adherence analysis at both 180 and 360 days ( n = 447 and n = 87, respectively), compared with patients receiving dulaglutide ( n = 17,073 and n = 7280, respectively) (Table 2), liraglutide ( n = 11,996 and n = 6137, respectively), and exenatide QW ( n = 5842 and n = 2683, respectively)
It is important to maintain adequate hydration whilst taking Ozempic, as dehydration from gastrointestinal side effects could potentially worsen kidney function
They also improve overall health
Our results confirmed these findings
After 12 weeks at a stable, therapeutic dose without meaningful weight loss, it's time to discuss alternatives with your prescriber